Dyadic International Inc (DYAI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Dyadic International Inc (DYAI) has a cash flow conversion efficiency ratio of -0.710x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.85 Million) by net assets ($2.61 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DYAI company net worth for the company's overall valuation and market capitalisation.
Dyadic International Inc - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Dyadic International Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Dyadic International Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Dyadic International Inc ranked by their cash flow conversion efficiency. Explore Dyadic International Inc (DYAI) cash earnings ratio to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DELPHI WORLD MONEY LIMITED
NSE:DELPHIFX
|
0.271x |
|
MRO-TEK Realty Limited
NSE:MRO-TEK
|
0.014x |
|
Smartiks Yazilim AS
IS:SMART
|
0.098x |
|
Nextedia
PA:ALNXT
|
-0.050x |
|
Klassik Radio AG
XETRA:KA8
|
0.160x |
|
Minox International Group Berhad
KLSE:0288
|
0.026x |
|
Japan Gold Corp
V:JG
|
-0.051x |
|
Taihan Textile
KO:001070
|
-0.044x |
Annual Cash Flow Conversion Efficiency for Dyadic International Inc (2003–2024)
The table below shows the annual cash flow conversion efficiency of Dyadic International Inc from 2003 to 2024. View Dyadic International Inc (DYAI) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.47 Million | $-3.97 Million | -1.609x | -40.62% |
| 2023-12-31 | $5.88 Million | $-6.73 Million | -1.144x | -56.95% |
| 2022-12-31 | $11.09 Million | $-8.08 Million | -0.729x | -18.90% |
| 2021-12-31 | $18.39 Million | $-11.28 Million | -0.613x | -165.32% |
| 2020-12-31 | $28.45 Million | $-6.57 Million | -0.231x | -43.33% |
| 2019-12-31 | $35.86 Million | $-5.78 Million | -0.161x | -55.31% |
| 2018-12-31 | $42.45 Million | $-4.41 Million | -0.104x | -99.07% |
| 2017-12-31 | $49.98 Million | $-2.61 Million | -0.052x | +50.15% |
| 2016-12-31 | $57.69 Million | $-6.04 Million | -0.105x | -861.81% |
| 2015-12-31 | $73.79 Million | $-802.67K | -0.011x | -100.40% |
| 2014-12-31 | $-2.26 Million | $-6.20 Million | 2.738x | +37.97% |
| 2013-12-31 | $2.57 Million | $5.10 Million | 1.984x | +871.06% |
| 2012-12-31 | $1.79 Million | $365.17K | 0.204x | -95.50% |
| 2011-12-31 | $-800.00K | $-3.63 Million | 4.538x | +244.91% |
| 2010-12-31 | $2.44 Million | $-7.64 Million | -3.131x | -432.71% |
| 2009-12-31 | $6.96 Million | $6.55 Million | 0.941x | +110.68% |
| 2008-12-31 | $1.46 Million | $-12.87 Million | -8.815x | -687.58% |
| 2007-12-31 | $13.50 Million | $-15.11 Million | -1.119x | -4091.22% |
| 2006-12-31 | $28.19 Million | $790.51K | 0.028x | +105.52% |
| 2005-12-31 | $15.38 Million | $-7.82 Million | -0.508x | -111.04% |
| 2004-12-31 | $24.57 Million | $-5.92 Million | -0.241x | -113.89% |
| 2003-12-31 | $-74.09K | $-128.49K | 1.734x | -- |
About Dyadic International Inc
Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells industrial enzymes and other proteins in the United States and internationally. It utilizes the C1 platform in pharmaceutical applications, including the development and production of pharmaceutical products. The company offers Dapibus, a protein production platform that enable the rapid development and la… Read more